A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC).

Ashokkumar A. Patel, John R. Gilbertson, Louise C. Showe, Jack London, Eric A. Ross, Michael F. Ochs, Joseph R. Carver, Andrea Lazarus, Anil V. Parwani, Rajiv Dhir,

PubMed · 2007 · 23 citations · 13 references

Full text

Open access

Concepts

TL;DR

PCABC is a pioneering, four‑year, state‑funded consortium launched by the Pennsylvania Cancer Alliance to build a bioinformatics infrastructure. The consortium aims to create a statewide virtual biorepository and bioinformatics platform that stores, shares, and analyzes clinical specimens and biomarker data, thereby enabling biomarker discovery and collaborative cancer research across Pennsylvania institutions. It achieves this by developing a shared data warehouse, statewide data models, a public portal, and coordinating close collaboration among member institutions to share clinical, genomic, and other bioinformatics data on patient samples.

Abstract

The Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC, http://www.pcabc.upmc.edu) is one of the first major project-based initiatives stemming from the Pennsylvania Cancer Alliance that was funded for four years by the Department of Health of the Commonwealth of Pennsylvania. The objective of this was to initiate a prototype biorepository and bioinformatics infrastructure with a robust data warehouse by developing a statewide data model (1) for bioinformatics and a repository of serum and tissue samples; (2) a data model for biomarker data storage; and (3) a public access website for disseminating research results and bioinformatics tools. The members of the Consortium cooperate closely, exploring the opportunity for sharing clinical, genomic and other bioinformatics data on patient samples in oncology, for the purpose of developing collaborative research programs across cancer research institutions in Pennsylvania. The Consortium's intention was to establish a virtual repository of many clinical specimens residing in various centers across the state, in order to make them available for research. One of our primary goals was to facilitate the identification of cancer-specific biomarkers and encourage collaborative research efforts among the participating centers.

References

13